Home Based Infusions for Ocrelizumab
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Home Based Infusions for Ocrelizumab is a clinical trial[1].
Key Facts
- Home Based Infusions for Ocrelizumab's instance of is recorded as clinical trial[2].
- Home Based Infusions for Ocrelizumab's start time is recorded as +2021-02-01T00:00:00Z[3].
- Home Based Infusions for Ocrelizumab's end time is recorded as +2021-12-31T00:00:00Z[4].
- Home Based Infusions for Ocrelizumab's contributor to the creative work or subject is recorded as Genentech[5].
- Home Based Infusions for Ocrelizumab's sponsor is recorded as University of Colorado Denver[6].
- Home Based Infusions for Ocrelizumab's main subject is recorded as multiple sclerosis[7].
- Home Based Infusions for Ocrelizumab's number of participants is recorded as {'unit': '1', 'amount': '+110'}[8].
- Home Based Infusions for Ocrelizumab's title is recorded as Evaluating the Feasibility of Pandemic Forward, Telehealth Based Home Based Infusions[9].
- Home Based Infusions for Ocrelizumab's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Home Based Infusions for Ocrelizumab's ClinicalTrials.gov ID is recorded as NCT04650321[11].
- Home Based Infusions for Ocrelizumab's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[12].
- Home Based Infusions for Ocrelizumab's research intervention is recorded as ocrelizumab[13].
- Home Based Infusions for Ocrelizumab's clinical trial phase is recorded as phase IV clinical trial[14].
- Home Based Infusions for Ocrelizumab's research subject recruitment status is recorded as not yet recruiting[15].
- Home Based Infusions for Ocrelizumab's study type is recorded as interventional study[16].